Skip to main content
Recordati Industria Chimica e Farmaceutica S.p.A. (RCDTF)
OTCMKTS · Delayed Price · Currency is USD
56.04
+7.04 (14.37%)
Apr 24, 2025, 10:47 AM EDT

RCDTF Revenue

In the year 2024, Recordati Industria Chimica e Farmaceutica had annual revenue of 2.34B EUR with 12.45% growth. Recordati Industria Chimica e Farmaceutica had revenue of 598.48M in the quarter ending December 31, 2024, with 13.75% growth.

Revenue
2.34B EUR
Revenue Growth
+12.45%
P/S Ratio
4.74
Revenue / Employee
510.92K EUR
Employees
4,583
Market Cap
11.49B USD

Revenue Chart

* This company reports financials in EUR.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20242.34B259.23M12.45%
Dec 31, 20232.08B229.02M12.36%
Dec 31, 20221.85B273.23M17.29%
Dec 31, 20211.58B131.21M9.06%
Dec 31, 20201.45B-32.98M-2.23%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
SS Innovations International 20.65M
Endo Inc. 1.76B
Veradigm 588.02M
Elite Pharmaceuticals 70.00M
Northwest Biotherapeutics 1.38M
Glass House Brands 200.90M
BioStem Technologies 301.83M
American Oncology Network 1.76B
Revenue Rankings

Recordati Industria Chimica e Farmaceutica News

More News